CRISPR

YTD

ALL

Trade CRISPR 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.

CEO

Samarth Kulkarni

CEOSamarth Kulkarni

Employees

393

Employees393

Headquarters

Zug, Zug

HeadquartersZug, Zug

Founded

2013

Founded2013

Employees

393

Employees393

CRSP Key Statistics

Market cap

3.28B

Market cap3.28B

Price-Earnings ratio

-8.18

Price-Earnings ratio-8.18

Dividend yield

—

Dividend yield—

Average volume

1.89M

Average volume1.89M

High today

$38.14

High today$38.14

Low today

$36.08

Low today$36.08

Open price

$37.43

Open price$37.43

Volume

1.84M

Volume1.84M

52 Week high

$67.88

52 Week high$67.88

52 Week low

$30.04

52 Week low$30.04

Analyst ratings

59%

of 29 ratings

Buy

58.6%

Hold

37.9%

Sell

3.4%

People also own

Based on the portfolios of people who own CRSP. This list is generated using Robinhood data, and it’s not a recommendation.

Intellia Therapeutics